Tag Archives: Patrick Soon-Shiong

medical.research

PCH forms pediatric genomics institute

Dr. Patrick Soon-Shiong joined Phoenix Children’s Hospital to announce the formation of a visionary institute, The Chan Soon-Shiong Children’s Precision Medicine Institute at Phoenix Children’s Hospital.

The new partnership brings together the medical expertise and resources of renowned surgeon and healthcare technology visionary Patrick Soon-Shiong, MD, with Phoenix Children’s commitment to genomic research and access to a large pediatric patient base. The institute will transform the pediatric health care landscape by applying state-of-the-art genomic and proteomic technology to identify precision diagnoses, treatments and cures for young patients facing serious illnesses.

“Our goal is to bring genomics research to the forefront of pediatrics,” said Robert L. Meyer, president and CEO of Phoenix Children’s Hospital. “With Dr. Soon-Shiong’s transformative technology implemented at Phoenix Children’s, the realization of all children having access to life-saving precision medicine becomes one step closer.”

Soon-Shiong is the founder of Nantworks, largely dedicated to applying genomic and proteomic analysis studies to translate diagnoses and cures more quickly and accurately. To date, his efforts have been focused on the adult population. Through this institute, Phoenix Children’s will serve as the exclusive national hub for pediatric genomic research and translational precision medicine.

“Phoenix Children’s is unique among children’s hospitals,” noted Dr. Soon-Shiong. “The leadership and the board of this hospital are leading their peers in health care by executing on an operational principle of patient centered 21st century care. They have attracted talented researchers and clinical scientists and have demonstrated their ability to advance a vision for precision medicine in pediatrics.”

At the crux of this revolutionary undertaking is super computing cloud based technology and artificial intelligence. Phoenix Children’s will be home to one of the few dedicated supercomputers in the country, which can deliver genomic sequencing and analysis more quickly than ever before. Appropriate patients undergo full genome sequencing and proteomics analysis in an unprecedented seven days.

“Current genome sequencing takes time,” added Meyer. “And that’s something that these patients don’t have. The mission is to develop innovative and effective diagnostics and therapies for young patients, while empowering physicians with the most up-to-date research and therapeutic models available, all to deliver potentially life-saving treatments.”

Often, existing treatment protocols lack efficacy for patients; this new genomic analysis will alter that dynamic through specific and targeted therapeutic remedies based on the individual’s unique genetic makeup. In time, Soon-Shiong’s technology will lead to a comprehensive genomic database platform, from which a shared information consortium will be integrated into a global diagnosis, treatment, and result-based methodology. A vast bank of pediatric patient data will be generated via a consortium of children’s hospitals, led by Phoenix Children’s.

“The Chan Soon-Shiong Children’s Precision Medicine Institute will fundamentally alter the way pediatric health care is delivered around the world,” said Meyer.

bioscience

Jewett Named Arizona Bioscience Leader of the Year

jewett-sqJack B. Jewett, President & CEO of the Flinn Foundation, will be honored with the Jon W. McGarity Arizona Bioscience Leader of the Year Award by the Arizona BioIndustry Association.

“Great leaders embrace possibilities and take the steps to make them reality. Jack B. Jewett has done more than just take steps,” shared Joan Koerber-Walker, President & CEO, of the Arizona Bioindustry Association. “Thanks to his leadership and the commitment of the Flinn Foundation, Arizona has a Bioscience Roadmap that charts our statewide bioscience strategies through 2025.”

A longtime Arizona leader in health care, education, and public policy, Mr. Jewett joined the Flinn Foundation in June 2009 as President & CEO. In this role, he is responsible for all grant programs and operations of the Flinn Foundation including Arizona’s Bioscience Roadmap, which is the longest running bioscience strategic initiative of its kind in the US. Under Jewett’s leadership, Flinn has renewed its commitment and released the next generation of the Roadmap extending out until 2025.

Mr. Jewett previously served in a variety of leadership roles within the private, public, and nonprofit sectors in Arizona for more than 40 years. He held senior public policy and government relations positions with Tucson Medical Center for 13 years and served as president of Territorial Newspapers, a family-owned publishing and printing company in Tucson. He served on the Arizona Board of Regents from 1998-2006, including a term as president; and five terms in the Arizona House of Representatives, from 1983-1992, the final two years as majority whip.

A University of Arizona graduate, Mr. Jewett currently serves on the board of trustees of the Tucson-based Thomas R. Brown Foundations, is a public member of the Arizona Judicial Council, and is a member of the Greater Phoenix Leadership Council. He served on the board of directors for the National Association of Governing Boards of Universities and Colleges from 2004-13, and received its Distinguished Service Award for outstanding trusteeship for his work on “Changing Directions,” an initiative of the Arizona Board of Regents.

The Flinn Foundation is a privately endowed, philanthropic grantmaking organization established in 1965 by Dr. Robert S. and Irene P. Flinn to improve the quality of life in Arizona to benefit future generations. Today, the Foundation supports the advancement of the biosciences in Arizona, as well as three other program areas to help build Arizona’s knowledge-driven economy.

A ceremony honoring Jack B. Jewett will take place at the AZBio Awards Sept. 17 at the Phoenix Convention Center. The AZBio Awards ceremony celebrates Arizona’s leading educators, innovators and companies. Each year, AZBio honors bioindustry leaders from across the state of Arizona who are illustrative of the depth, breadth and expertise of our bioscience industry.

Past recipients of the Jon W. McGarity Arizona Bioscience Leader of the Year Award include: Linda Hunt (Dignity Health), Harry George (Solstice Capital), Robert Penny, MD, PhD (International Genomics Consortium), Patrick Soon-Shiong, MD (NantHealth), Martin L. Shultz (Pinnacle West Capital Corp.), Michael Cusanovich, Ph.D., (University of Arizona), Jonathan Thatcher (Exeter Life Sciences), John W. Murphy (Flinn Foundation), and George Poste (Arizona State University).

For registration and more information, go to www.azbio.awards.com.